Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.

Kalil AC, Murthy MH, Hermsen ED, Neto FK, Sun J, Rupp ME.

Crit Care Med. 2010 Sep;38(9):1802-8. doi: 10.1097/CCM.0b013e3181eb3b96. Review.

PMID:
20639754
2.

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.

Jiang H, Tang RN, Wang J.

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1121-8. doi: 10.1007/s10096-013-1867-z. Epub 2013 Apr 10. Review.

PMID:
23568605
3.

Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.

Wang Y, Zou Y, Xie J, Wang T, Zheng X, He H, Dong W, Xing J, Dong Y.

Eur J Clin Pharmacol. 2015 Jan;71(1):107-15. doi: 10.1007/s00228-014-1775-x. Epub 2014 Oct 30. Review.

PMID:
25355172
4.
5.

[Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].

Lin ZQ, Huang YL, Huang P, Chen Q.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Dec;33(12):900-6. Chinese.

PMID:
21211409
7.

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.

Shorr AF, Kunkel MJ, Kollef M.

J Antimicrob Chemother. 2005 Nov;56(5):923-9. Epub 2005 Sep 29.

8.

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

Beibei L, Yun C, Mengli C, Nan B, Xuhong Y, Rui W.

Int J Antimicrob Agents. 2010 Jan;35(1):3-12. doi: 10.1016/j.ijantimicag.2009.09.013. Epub 2009 Nov 8. Review.

PMID:
19900794
9.

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP.

J Antimicrob Chemother. 2004 Feb;53(2):345-55. Epub 2004 Jan 7.

10.
11.

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

Nasraway SA, Shorr AF, Kuter DJ, O'Grady N, Le VH, Cammarata SK.

Clin Infect Dis. 2003 Dec 15;37(12):1609-16. Epub 2003 Nov 20.

12.

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Rubinstein E, Cammarata S, Oliphant T, Wunderink R; Linezolid Nosocomial Pneumonia Study Group.

Clin Infect Dis. 2001 Feb 1;32(3):402-12. Epub 2001 Jan 26.

13.

Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.

De Cock E, Krueger WA, Sorensen S, Baker T, Hardewig J, Duttagupta S, Müller E, Piecyk A, Reisinger E, Resch A.

Infection. 2009 Apr;37(2):123-32. doi: 10.1007/s15010-008-8046-7. Epub 2009 Mar 9.

PMID:
19277465
14.

Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Mullins CD, Kuznik A, Shaya FT, Obeidat NA, Levine AR, Liu LZ, Wong W.

Clin Ther. 2006 Aug;28(8):1184-98.

PMID:
16982296
15.

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.

Wilcox M, Nathwani D, Dryden M.

J Antimicrob Chemother. 2004 Feb;53(2):335-44. Epub 2004 Jan 16.

16.

[Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].

Taşbakan MS, Korkmaz Ekren P, Pullukçu H, Başarık B, Susur A, Aydemir S, Başoğlu OK, Bacakoğlu F.

Mikrobiyol Bul. 2010 Jul;44(3):357-66. Turkish.

PMID:
21063985
17.

Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.

Maclayton DO, Hall RG 2nd.

Ann Pharmacother. 2007 Feb;41(2):235-44. Epub 2007 Feb 13. Review.

PMID:
17299012
18.

[Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study].

Grudinina SA, Zubkov MM, Krotova LA, Kurdiukova IuP, Kutsenko MA, Marinin VF, Sidorenko SV, Sinpal'nikov AI, Solomatin AS, Sterkhova GV, Fesenko OV, Fomina IG, Chuchalin AG.

Antibiot Khimioter. 2002;47(1):12-7. Russian.

PMID:
12077934
19.

Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Puzniak LA, Morrow LE, Huang DB, Barreto JN.

Clin Ther. 2013 Oct;35(10):1557-70. doi: 10.1016/j.clinthera.2013.08.001. Epub 2013 Sep 3.

PMID:
24011955
20.

Update on linezolid: the first oxazolidinone antibiotic.

Wilcox MH.

Expert Opin Pharmacother. 2005 Oct;6(13):2315-26. Review.

PMID:
16218891
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk